Theophylline Tablet, Extended Release
Product Images NDC 82638-106

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Theophylline (NDC 82638-106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Harman Finochem Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Description (Theophylline 300mg)

Each uncoated extended-release tablet contains Theophyline (Anhydrous) USP 300 mg. The tablets are manufactured by Harman Finochem Limited in Maharashtra, India. Store at 20°-25° C (68°-77°F). These extended-release tablets should be dispensed in a well-closed container with child-resistant closure. Follow the usual dosage as per the package insert. Note that the product is for Rx only.*

FDA Label Image

Image Description (Theophylline 450mg)

FDA Label Image

Image Description (Theophylline Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.